Technical Analysis for BEAM - Beam Therapeutics Inc.

Grade Last Price % Change Price Change
D 73.49 -12.26% -10.27
BEAM closed down 12.26 percent on Thursday, March 4, 2021, on 2.18 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical BEAM trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Multiple of Ten Bearish Other -12.26%
Older End-of-Day Signals for BEAM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1 ATR about 7 hours ago
60 Minute Opening Range Breakdown about 8 hours ago
Down 10% about 8 hours ago
3x Volume Pace about 10 hours ago
2x Volume Pace about 10 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. It is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Gene Therapy Acute Myeloid Leukemia Nervous System Disorders Central Nervous System Disorders Leukemia Serious Diseases Acute Lymphoblastic Leukemia Antitrypsin Deficiency Sickle Cell Disease Thalassemia Acute Leukemia Beta Thalassemia Glycogen Storage Disorder

Is BEAM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 126.9
52 Week Low 13.0
Average Volume 1,087,612
200-Day Moving Average 48.48
50-Day Moving Average 97.50
20-Day Moving Average 101.17
10-Day Moving Average 93.36
Average True Range 10.93
ADX 20.08
+DI 18.61
-DI 34.98
Chandelier Exit (Long, 3 ATRs ) 94.11
Chandelier Exit (Short, 3 ATRs ) 102.00
Upper Bollinger Band 123.94
Lower Bollinger Band 78.40
Percent B (%b) -0.11
BandWidth 45.01
MACD Line -3.76
MACD Signal Line -0.24
MACD Histogram -3.5222
Fundamentals Value
Market Cap 4.26 Billion
Num Shares 58 Million
EPS -2.01
Price-to-Earnings (P/E) Ratio -36.59
Price-to-Sales 115294.55
Price-to-Book 15.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 97.59
Resistance 3 (R3) 98.84 92.06 93.57
Resistance 2 (R2) 92.06 85.92 91.43 92.23
Resistance 1 (R1) 82.77 82.13 79.38 81.52 90.89
Pivot Point 75.99 75.99 74.30 75.37 75.99
Support 1 (S1) 66.71 69.85 63.32 65.46 56.09
Support 2 (S2) 59.93 66.06 59.30 54.75
Support 3 (S3) 50.64 59.93 53.41
Support 4 (S4) 49.39